LABFF Stock: Laboratorios Farmaceuticos Rovi, S.A. Stock Price, Analysis & Insights
Get live LABFF stock price $90.61, comprehensive Laboratorios Farmaceuticos Rovi, S.A. stock analysis, charts, news, and expert forecast. Real-time LABFF stock data and investment insights.
Loading chart data...
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Overview
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, LABFF trades at $90.61 with a market capitalization of 4.63B . Over the past 52 weeks, LABFF has traded between $90.61 and $90.61 , with the current price positioned at approximately Na...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 4.63B
- Current price: $90.61
- 52-week range: $90.61 - $90.61
- P/E ratio: 28.95
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical firm actively involved in the discovery, creation, manufacturing, and commercialization of medicinal products. Its market presence extends across Spain, the European Union, OECD nations, and o...
Company Information
- CEO
- Juan Lopez-Belmonte Encina
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 2197
Contact Information
- Website
- https://www.rovi.es
- Address
- Calle José Isbert, 2
- Country
- ES
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 28.9)
✓ Lower volatility stock (Beta: 0.22) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Laboratorios Farmaceuticos Rovi, S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Laboratorios Farmaceuticos Rovi, S.A.
- ⚠Investors should consider how Laboratorios Farmaceuticos Rovi, S.A. fits within their overall portfolio allocation
Market Cap
4.63B
P/E Ratio (TTM)
28.95
Beta
0.22
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare LABFF with peer companies:
- Price
- $38.89
- Market cap
- 7.83B
- Price
- $58.00
- Market cap
- 3.45B
- Price
- $37.06
- Market cap
- 2.94B
- Price
- $29.86
- Market cap
- 2.61B
- Price
- $1.60
- Market cap
- 3.50B
- Price
- $1.55
- Market cap
- 2.32B
- Price
- $100.00
- Market cap
- 4.38B
- Price
- $3.35
- Market cap
- 4.84B
- Price
- $16.41
- Market cap
- 3.42B
- Price
- $43.66
- Market cap
- 3.09B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.